White House Demands FDA Chief's Top Aide Resignation Amid Rising Tensions
Image Source: Internet
The White House has requested the resignation of Sanjula Jain-Nagpal, a top aide to U.S. Food and Drug Administration (FDA) Commissioner Marty Makary, amidst growing tensions between Makary and the administration. According to Politico, the White House cited Makary's attempt to promote Jain-Nagpal, a policy and research staffer at the FDA, without approval. Makary had sought to elevate Jain-Nagpal's position, which the White House had not yet endorsed. In response, the administration asked the Department of Health and Human Services (HHS) to request her resignation. However, Makary reportedly pushed back against the move, and an HHS spokesperson confirmed that Jain-Nagpal remains an FDA employee. The development marks the latest escalation in a series of controversies surrounding Makary, who has faced criticism from the White House and HHS leadership. The FDA has recently undergone changes, with the appointment of Richard Pazdur as the head of the department responsible for reviewing new medicines, following the resignation of George Tidmarsh over concerns about his personal conduct. Tensions between Makary and the administration have been building in recent weeks, with officials, including former Health Secretary Robert F. Kennedy Jr., discussing plans to limit Makary's authority. The situation raises questions about the future of the FDA under Makary's leadership and the potential impact on the agency's policies and decisions.
